SARS-CoV-2 Virus-like Particles Produced by a Single Recombinant Baculovirus Generate Anti-S Antibody and Protect against Variant Challenge

Coronavirus Disease 2019 (COVID-19), caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has highlighted the need for the rapid generation of efficient vaccines for emerging disease. Virus-like particles, VLPs, are an established vaccine technology that produces vi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sullivan, Edward, Sung, Po-Yu, Wu, Weining, Berry, Neil, Kempster, Sarah, Ferguson, Deborah, Almond, Neil, Jones, Ian M., Roy, Polly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143203/
https://www.ncbi.nlm.nih.gov/pubmed/35632656
http://dx.doi.org/10.3390/v14050914

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143203/
https://www.ncbi.nlm.nih.gov/pubmed/35632656
http://dx.doi.org/10.3390/v14050914

Ejemplares similares